Skip to main content
FMCFMC CorporationSell5.0·$4.47
SellModerate Confidence
Investment thesis

The stock trades at a forward price-to-earnings multiple of 5.2x with roughly 33% headroom to the analyst consensus target and has beaten or matched estimates in all four of the last four reported quarters, but quality sits well below the minimum threshold — a Piotroski score of 3 out of 9, no competitive moat — revenue is contracting 4% year over year, a confirmed death-cross technical pattern has triggered a hard block, and 18% short interest signals that the market views the depressed multiple as earned rather than as a value opportunity.

Thesis pillars

  • Death Cross Falling Knife Downtrend→Stable
  • Deep Discount Offset By Justified Short Interest↓Deteriorating
  • Quality Floor Breach Weak Fundamentals→Stable
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Feb 27, 2026

Full reasoning →

Open full analysis

FMC Corporation (FMC) Stock Analysis

Falling Knife setup · Sector Rotation edge

SellValueGrowthShortModerate Confidence

Basic Materials · Agricultural Inputs

Earnings today — results expected after close (2026-10-29). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Engine safety override at $4.47: Quality below floor (3.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10 and A.R:R 5.0:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 24%; Below-average business quality; Negative price momentum.

FMC Corporation develops, markets, and sells crop protection chemicals — insecticides, herbicides, fungicides — plus biologicals and plant health products in a single global segment, employing approximately 5,500 people across four regions. Revenue comes from proprietary active... Read more

$4.47+75.4% A.UpsideScore 5.0/10#8 of 9 Agricultural Inputs
QualityF-score6 / 9FCF yield23.82%
IncomeYield7.16%(5y avg 3.11%)Payout223.08%at-risk
Stop $4.24Analyst target $7.84(−10% haircut)A.R:R 5.0:1
Analyst consensus$8.71+94.9%15 analysts
$7.84Analyst target
$4.47price
$8.71mean
$18

Sell if holding. Engine safety override at $4.47: Quality below floor (3.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10 and A.R:R 5.0:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 24%; Below-average business quality; Negative price momentum. Chart setup: Death cross, below all MAs, RSI 4, MACD bearish. Score 5.0/10, moderate confidence.

Passes 5/9 gates (favorable risk/reward ratio, clean insider activity, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA) and earnings proximity 0d<=7d. Suitability: speculative.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-29

Recent Developments — FMC Corporation

Generated 2026-10-29T11:48:39Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Oct 29, 2026Earnings today — results expected after close· next earnings call

Thesis

Rewards
No bull case signals
Risks
Quality below floor (3.0 < 4.0)

Key Metrics

P/E (TTM)—
P/E (Fwd)3.2
Mkt Cap$695M
EV/EBITDA16.7
Profit Mgn-84.8%
ROE-88.4%
Rev Growth-17.5%
Beta0.46
Dividend7.16%
Rating analysts23

Quality Signals

Piotroski F6/9

Options Flow

P/C1.00neutral
IV116%elevated

Concentration Risks(10-K Item 1A)

  • MEDIUMProductRynaxypyr® active
    10-K Item 1: 'Rynaxypyr® active (chlorantraniliprole), the world's leading insect control technology – with annual revenues of approximately $0.8 billion in 2025'
  • LOWProductCyazypyr® active
    10-K Item 1: 'Cyazypyr® active (cyantraniliprole), which supports a portfolio of products that generated revenues of approximately $0.4 billion in 2025'
  • MEDIUMSupplierChina and India intermediates
    10-K Item 1A: 'We source critical intermediates and finished products from a number of suppliers, largely outside of the U.S. and principally in China and India'

Material Events(8-K, last 90d)

  • 2026-04-29Item 5.02LOW
    Board director Dirk A. Kempthorne, a member of the FMC board since 2009, passed away. No successor named. The 2026 Incentive Stock Plan was separately approved at the April 28, 2026 Annual Meeting, replacing the 2023 plan.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

3 floor-breakers

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
0.0
Growth Rank
0.0
Value Rank
8.9

Cyclical trough — margins compressed or negative. Profitability typically recovers with the cycle, but floor fires on current data.static

Roe
0.0
Net Margin
0.0
Roa
0.4
Gross Margin
2.4
Moat
2.5
Operating Margin
4.7
Piotroski F
6.7
Current Ratio
7.0
No competitive moatQuality concerns

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.9
Ma Position
1.0
Volume
2.9
Rsi
3.0
Obv
10.0
Capitulation risk (RSI 4, below 200MA)Volume accumulation (rising OBV)Below 200-MA, MA slope -6.5%/30d — confirmed downtrend
GatesMomentum 3.6<4.5Death cross (50MA < 200MA)EARNINGS PROXIMITY 0d<=7dExecutive change: officer departure/appointmentA.R:R 5.0 ≥ 1.5Insider activity: OKNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARFalling KnifeSuitability: Speculative
RSI
4 · Oversold
↓ 20D MA↓ 50D MA↓ 200D MADEATH CROSSSupport $4.37Resistance $9.30

Price Targets

$4
$8
A.Upside+75.4%
A.R:R5.0:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeSteady

Risk Alerts

! Quality below floor (3.0 < 4.0)
! momentum at 3.6 (below the engine's 4.5 threshold)
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-10-29 (Earnings today — results expected after close)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is FMC stock a buy right now?

Sell if holding. Engine safety override at $4.47: Quality below floor (3.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10 and A.R:R 5.0:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 24%; Below-average business quality; Negative price momentum. Chart setup: Death cross, below all MAs, RSI 4, MACD bearish. Prior stop was $4.24. Score 5.0/10, moderate confidence.

What is the FMC stock price target?

Analyst target: $7.84 (+75.4% upside). Prior stop was $4.24. Stop-loss: $4.24.

What are the risks of investing in FMC?

Quality below floor (3.0 < 4.0).

Is FMC overvalued or undervalued?

FMC Corporation trades at a P/E of N/A (forward 3.2). TrendMatrix value score: 7.2/10. Verdict: Sell.

What do analysts say about FMC?

23 analysts cover FMC with a consensus score of 3.3/5. Average price target: $9.

What does FMC Corporation do?FMC Corporation develops, markets, and sells crop protection chemicals — insecticides, herbicides, fungicides — plus...

FMC Corporation develops, markets, and sells crop protection chemicals — insecticides, herbicides, fungicides — plus biologicals and plant health products in a single global segment, employing approximately 5,500 people across four regions. Revenue comes from proprietary active ingredients; Rynaxypyr® active generated approximately $0.8 billion in 2025, with Cyazypyr® active brands at approximately $0.4 billion. In February 2026, the Board authorized a strategic review including potential sale of the company.

Related stocks: UAN (CVR Partners, LP) · ICL (ICL Group Ltd.) · IPI (Intrepid Potash, Inc) · SMG (Scotts Miracle-Gro Company (The) · MOS (Mosaic Company (The))
Home › Stocks › FMC

Latest news

Latest News

Benzinga10d agoAnalyst
Benzinga13d agoAnalyst
Benzinga13d agoAnalyst
Benzinga13d ago
Benzinga13d ago
Benzinga13d ago
Benzinga13d ago
Benzinga14d ago
Benzinga14d agoAnalyst
Benzinga14d agoEarnings
Benzinga14d ago
Benzinga14d agoEarnings
Benzinga16d ago
Benzinga24d agoAnalyst
Benzinga31d agoProduct
Benzinga31d ago
Benzinga35d ago
Benzinga42d agoProduct
Benzinga62d ago
Benzinga90d agoAnalyst
Loading more...